Patents/Assignees

ABCLON Inc.

4 patents in portfolio

US12414998utility2025
Anti-her2 Affibody and Switchable Chimeric Antigen Receptor Using Same as Switch Molecule
0 cites
US12090171utility2024
Antibody or Antigen Binding Fragment Thereof for Specifically Recognizing B Cell Malignancy, Chimeric Antigen Receptor Comprising Same and Use Thereof
0 cites
US11945878utility2024
Switch Molecule and Switchable Chimeric Antigen Receptor
0 cites
US11708409utility2023
Antibody or Antigen-binding Fragment Thereof That Specifically Recognizes B Cell Malignancies, Chimeric Antigen Receptor Comprising Same, and Uses Thereof
0 cites